Intel (INTC) Buys 10% Stake in Eye-Tracking Device Developer Tobii
Tweet Send to a FriendGet Alerts INTC Hot Sheet
Price: $23.92 -0.54%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 3.8%
EPS Growth %: -28.6%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 3.8%
EPS Growth %: -28.6%
Trade INTC Now!
Intel (Nasdaq: INTC) has invested $21 million for a 10 percent working stake in Tobii.
According to TechCrunch, Tobii is "a Swedish company that has been working for years on eye-tracking laptops and other devices."
Tobii isn't profitable and saw a net loss of about $3.5 million in 2010. The company did just release its next-generation eye tracking integration component, the Tobii IS-2 Eye Tracker, just last week. Tobii notes that the new device is "is smaller, cheaper, better, and draws less power than its predecessor."
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
According to TechCrunch, Tobii is "a Swedish company that has been working for years on eye-tracking laptops and other devices."
Tobii isn't profitable and saw a net loss of about $3.5 million in 2010. The company did just release its next-generation eye tracking integration component, the Tobii IS-2 Eye Tracker, just last week. Tobii notes that the new device is "is smaller, cheaper, better, and draws less power than its predecessor."
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- Sonic Automotive (SAH) Buys Murray BMW of Denver and Mercedes-Benz of Denve
- AMD (AMD) Slips Two Spots in Global MPU Sales for 2012; Intel (INTC) Drops Share
Create E-mail Alert Related Categories
Mergers and AcquisitionsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

